Condition
Haemoptysis
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown3
Clinical Trials (3)
Showing 3 of 3 trials
NCT02816229Not ApplicableUnknownPrimary
Endobronchial Valves in Inoperable Patients With Haemoptysis
NCT02878447Not ApplicableUnknownPrimary
The Utility of Radiotherapy in the Management of Haemoptysis Secondary to Aspergillomata and Structural Lung Diseases
NCT02913365Unknown
Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis
Showing all 3 trials